Breast implant alternative startup Tensive has received a €20 million loan from the European Investment Bank to fund research, clinical studies, and commercialization efforts for its bioresorbable scaffolds. This financing is a part of Tensive's larger €40 million financing plan. The EIB funding enables Tensive to advance its recently reported clinical results towards an available product for European surgeons. This commitment also supports ongoing equity financing efforts of the company.
Company Information
Company
Tensive
Location
Milan, Lombardy, Italy
About
Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer.
Don't miss Tensive's next move
Get an email the moment Tensive raises, hires an exec, or expands, usually minutes after it happens.